Last reviewed · How we verify
Raloxifene HCL
Raloxifene HCL is a Small molecule drug developed by Eli Lilly and Company. It is currently FDA-approved. Also known as: Evista, LY139481.
Raloxifene HCL is a small molecule used in the treatment of postmenopausal osteoporosis and breast cancer, as well as other conditions such as perimenopausal depression and schizophrenia in postmenopausal women. It has been studied in combination with teriparatide and alendronate in clinical trials.
At a glance
| Generic name | Raloxifene HCL |
|---|---|
| Also known as | Evista, LY139481 |
| Sponsor | Eli Lilly and Company |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Pharmacogenomics ANDA SNP Clinical Study - Raloxifene and Single Nucleotide Polymorphisms (PHASE2, PHASE3)
- New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia (PHASE2)
- Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain (PHASE2)
- XCHT for Irinotecan-Induced Gut Toxicities (Randomized Controlled Trial) (NA)
- Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian Syndrome (PHASE3)
- A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189) (PHASE3)
- XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study) (NA)
- Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Raloxifene HCL CI brief — competitive landscape report
- Raloxifene HCL updates RSS · CI watch RSS
- Eli Lilly and Company portfolio CI
Frequently asked questions about Raloxifene HCL
What is Raloxifene HCL?
Who makes Raloxifene HCL?
Is Raloxifene HCL also known as anything else?
What development phase is Raloxifene HCL in?
Related
- Manufacturer: Eli Lilly and Company — full pipeline
- Also known as: Evista, LY139481
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing